About this trial
Time-restricted eating (TRE) is a dietary manipulation that involves restricting food intake to 6-12 h/day with no energy intake the rest of the day. In rodents, TRE improves metabolic function without caloric restriction, potentially by activating nutrient sensing mechanisms and effects on circadian oscillations. However, an understanding of the effect of TRE on cardiometabolic health in people is not clear and few studies have evaluated this issue. Accordingly, the investigators propose to conduct a randomized controlled trial in people with obesity and prediabetes to determine the effect of 9 h TRE for 12 weeks, without a change in body weight, on key metabolic outcomes that are risk factors for cardiovascular disease (CVD): 1) multi-organ insulin sensitivity; 2) 24 h metabolic homeostasis and diurnal rhythm; and 3) adipose tissue and skeletal muscle biology. The proposed studies will elucidate the cardiometabolic implications of TRE in people with obesity and prediabetes.
Eligibility criteria
Qualifiers
must be able to grant voluntary informed consent and comply with the study instructions
aged 25-75 years
men and women
body mass index 27-45 kg/m2
Disqualifiers
shift worker
fasting >12 h/day more than once a week
vegan
> once a week no food intake after ~1800 h
Trial design
Treatments tested in this trial
- Time restricted eating
- Extended eating window
- Healthy diet